The landscape of cannabis consumption in the United States has undergone a radical transformation over the past decade. No longer confined to the traditional act of smoking a joint, the modern cannabis market offers a vast, sophisticated array of delivery systems—from high-potency concentrates inhaled via dabbing to precision-dosed gummies and sublingual oils.
A groundbreaking study published August 8 in the journal Addictive Behaviors reveals that the way a person chooses to consume cannabis may be a vital, overlooked diagnostic clue for clinicians. Conducted by researchers at NYU Langone Health, the study suggests that individuals who utilize multiple methods of consumption—a segment termed the "polymodal group"—face significantly higher risks of developing cannabis use disorder (CUD) and daily dependency compared to those who stick to a single method.
The Evolution of Cannabis Consumption Patterns
For decades, public health messaging regarding cannabis was singular in its focus: smoking. However, the 2022-2023 National Survey on Drug Use and Health (NSDUH) paints a far more complex picture. With roughly 43.8 million Americans—or over 15 percent of the population aged 12 and older—reporting cannabis use within the last month, the methods of delivery have diversified exponentially.
To understand how these habits correlate with health outcomes, the NYU research team analyzed data from 17,732 adults who had consumed cannabis within the 30 days prior to the survey. Using advanced statistical modeling to categorize consumption habits, the researchers identified four distinct cohorts of users:
- The Smokers (48%): The largest group, who rely primarily on traditional combustion methods.
- The Smoke-and-Vape Hybrid (21%): Users who oscillate between smoking flower and vaping oils or distillates.
- The Edibles-Focused (17%): Users who primarily ingest cannabis via food or beverage products.
- The Polymodal Group (14%): A significant minority who utilize almost every available form of the drug, including smoking, vaping, dabbing, and edibles.
Chronology of the Research and Key Findings
The study serves as the first national analysis of how different cannabis consumption methods naturally cluster among the American populace. The research process began with the extraction of granular data from the 2022-2023 federal survey, allowing the team to cross-reference demographic data with behavioral habits.
A Stark Disparity in Usage Frequency
The findings regarding daily usage patterns were immediate and startling. Among the "polymodal" users, approximately 50 percent reported using cannabis every single day. By contrast, the prevalence of daily use dropped significantly in other categories: 31 percent among those who smoke and vape, 28 percent among exclusive smokers, and a mere 13 percent among those who primarily consume edibles.
The Correlation with Cannabis Use Disorder (CUD)
Perhaps the most concerning discovery of the study relates to clinical addiction. When researchers applied the criteria for cannabis use disorder—the medical diagnosis for addiction characterized by an inability to stop using the drug despite negative consequences—the polymodal group stood out.
- Polymodal Users: 67% met the criteria for CUD.
- Smoke-and-Vape Users: 47% met the criteria for CUD.
- Smokers: 36% met the criteria for CUD.
- Edibles-Focused: 15% met the criteria for CUD.
These statistics suggest a powerful correlation: the more varied an individual’s intake methods, the higher the likelihood that they are struggling with a dependency that interferes with their daily life.
Demographic Insights and the "Young Adult" Factor
The study did more than just quantify consumption; it illuminated who is using what. Age, in particular, proved to be a defining factor in consumption habits.
Young adults between the ages of 18 and 25 were disproportionately represented in the "polymodal" and "smoke-and-vape" categories, accounting for nearly one-third of both groups. This suggests that younger users are more likely to experiment with diverse delivery systems, perhaps due to greater social exposure or the novelty of newer, high-potency products like dabs or vape cartridges.
Conversely, the demographics for edible consumption skewed differently. Women made up more than 50 percent of the edibles-only cohort, and this demographic was more heavily populated by college graduates. While the study did not definitively conclude why these trends exist, the researchers hypothesize that lifestyle factors, professional constraints, and personal preferences for discretion may influence the choice of consumption method.
The Hidden Risks of Combustion
A secondary, yet critical, finding of the study involves the intersection of cannabis and tobacco use. The researchers observed that individuals who primarily smoke cannabis are statistically more likely to also smoke cigarettes.
"The strong tie between smoking cannabis and smoking cigarettes is of concern because this subset of people are breathing in a wider range of chemicals via combustion, and their lungs are at risk," explained Dr. Joseph J. Palamar, a professor in the Department of Population Health at NYU Grossman School of Medicine and the study’s senior author.
Because both tobacco and cannabis combustion produce carcinogenic tars and carbon monoxide, the combination poses a compounded threat to respiratory health. This finding underscores the need for healthcare providers to treat cannabis screening with the same rigor as tobacco screening, especially when patients report smoking as their primary method of intake.
Official Responses and Clinical Implications
Dr. Omar El-Shahawy, the study’s lead author and an assistant professor in the Department of Population Health at NYU, emphasizes that these results should act as a "red flag" for medical professionals.
"Asking patients not only whether but how they use cannabis could help clinicians identify when a fuller assessment may be warranted," Dr. El-Shahawy stated. He argues that clinical intake forms often lack the nuance required to detect high-risk patterns. If a patient indicates they use cannabis, the follow-up questions should immediately pivot to the variety of methods they employ.
The study also calls for a shift in public health messaging. For decades, the anti-cannabis narrative was built around the hazards of smoking. However, as the market shifts toward vaping and edibles, this narrative has become increasingly outdated.
"Public health messages about cannabis still focus mostly on smoking, but people now use the drug in many different ways," El-Shahawy noted. "For younger adults, that means talking about the risks of vaping and combining multiple forms, while for people who prefer edibles, the message is to ‘start low and go slow’ because the effects take time to kick in."
Future Directions and Study Limitations
While the data provides a compelling snapshot of current consumption trends, the research team is careful to acknowledge the limitations of their work. As an observational study, it establishes an association between polymodal use and addiction; it does not prove that the act of using multiple methods causes the addiction. It is possible that individuals with higher levels of dependency simply seek out more ways to consume the drug to maintain a specific level of intoxication or to circumvent building a tolerance to a single method.
Furthermore, the data relies on self-reported information. Stigma, memory gaps, and underreporting are inherent challenges in substance use research.
Moving forward, the NYU team intends to investigate the psychological motivations behind these patterns. For instance, are those who favor edibles seeking relief from chronic pain or sleep disorders, or are they attempting to avoid the health risks associated with inhalation? Understanding the "why" behind the "how" will be the next frontier in developing effective prevention and intervention strategies.
Conclusion
As cannabis continues to gain legal status and social acceptance across the United States, the nuances of how it is consumed have become a critical public health issue. The NYU Langone Health study serves as a necessary wake-up call, demonstrating that the diversity of consumption methods is not merely a matter of personal preference—it is a significant indicator of potential dependency.
For clinicians, the message is clear: when a patient presents with multiple methods of cannabis use, it is time to move beyond casual inquiry and toward a more comprehensive, evidence-based assessment of their health. As the industry continues to evolve, our approach to education and patient care must be equally dynamic, addressing not just the substance itself, but the sophisticated, often risky, ways in which it is being integrated into the lives of millions.
Funding and Acknowledgments:
This research was supported by the National Institutes of Health (NIH) through grant R01DA055675. Additional contributors included Dr. Mohsen Abbasi-Kangevari, Michelle He, Xiaoying Zheng, and Dr. Neal Doran of the University of California, San Diego.
